Bayer hits back over Indian complusory licence ruling

March 05 2013

Show more sharing options

German pharmaceutical company Bayer says it will appeal yesterday’s decision by India’s IP Appellate Board to uphold a compulsory licence granted over its cancer drug Nexavar

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

more from across site and SHARED ros bottom lb

More from across our site

Patents

Alston & Bird hire anticipates IP disputes focus

Michelle Clark, who has a generalist litigation background, plans to focus on IP disputes at Alston & Bird

Rani Mehta, April 15 2025

Patents

Breaking: Philips and Vivo settle SEP dispute

Philips and Vivo have entered into a licensing agreement, putting an end to a five-year-old telecom SEP dispute in India

Sukanya Sarkar, April 15 2025

Patents

Five minutes with...Stefan Müller, 2SPL Patent Attorneys

Stefan Müller discusses managing deadlines, the importance of reflection, and why IP is more than just a 'nice to have'

April 15 2025

Trademarks

Charlotte, North Carolina, USA Skyline Aerial

Stobbs US excited to disrupt ‘greedy’ IP market

The three founders of the IP firm’s new US offering say they plan to offer a unique proposition in a market fixated by the billable hour

Max Walters, April 14 2025

Why OpenAI opinion provides ‘roadmap’ for practitioners: counsel

The opinion provides useful guidance when it comes to how courts might consider contributory infringement, DMCA claims, and other issues in AI copyright cases

Rani Mehta, April 11 2025

Patents

This week on MIP: InterDigital leadership shake-up | Bristol-Myers Squibb beats Teva

Ericsson joining Avanci Video as a licensor and the EUIPO's plans for AI use were also among the top talking points this week

Sukanya Sarkar, April 11 2025

Managing IP Awards

Bird & Bird and HGF among major winners at Managing IP Awards

The 2025 EMEA ceremony, held at the Royal Lancaster Hotel in London, also recognised in-house practitioners and rising stars

Max Walters, April 11 2025

Patents

How Skrine is helping clients navigate Malaysia’s changing IP landscape

Leaders at Malaysian law firm Skrine explain why cost remains a major pain point for Malaysian businesses and how client service can help a firm stand out

Sukanya Sarkar, April 10 2025

Trademarks